Michael Castagna
Chief Executive Officer presso MANNKIND CORPORATION
Patrimonio netto: 9 M $ in data 29/02/2024
Profilo
Michael E.
Castagna is on the board of Pet Partners and Chief Executive Officer & Director at MannKind Corp.
In the past he occupied the position of Vice President-Global Commercial at Amgen, Inc., Executive Director-Immunology Franchise at Bristol Myers Squibb Co. and VP & Head-North America Biopharmaceuticals at Novartis AG and Vice President & Head-Biopharmaceuticals at Sandoz, Inc. (a subsidiary of Novartis AG).
Dr. Castagna received an undergraduate degree from Philadelphia College of Pharmacy, a doctorate from Massachusetts College of Pharmacy & Health Science and an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
MANNKIND CORPORATION
0.81% | 04/02/2024 | 2 184 090 ( 0.81% ) | 9 M $ | 29/02/2024 |
Posizioni attive di Michael Castagna
Società | Posizione | Inizio |
---|---|---|
MANNKIND CORPORATION | Chief Executive Officer | 25/05/2017 |
Pet Partners | Director/Board Member | - |
Precedenti posizioni note di Michael Castagna
Società | Posizione | Fine |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 14/03/2016 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/11/2012 |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/11/2010 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Director/Board Member | - |
NOVARTIS AG | Corporate Officer/Principal | - |
Formazione di Michael Castagna
Massachusetts College of Pharmacy & Health Science | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Philadelphia College of Pharmacy | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
AMGEN INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
MANNKIND CORPORATION | Health Technology |
NOVARTIS AG | Health Technology |
Aziende private | 3 |
---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Pet Partners |